Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 USD | +0.58% | -.--% | +526.50% |
Jun. 13 | AbbVie inks immune disorder drug licensing deal with China's FutureGen | RE |
May. 24 | Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+526.50% | 71.68M | |
+41.18% | 55.66B | |
-8.35% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.80% | 26.29B | |
-16.12% | 20.25B | |
+30.94% | 12.76B | |
+28.63% | 12.18B | |
-1.61% | 12.12B |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Landos Biopharma to Implement 1-for-10 Reverse Stock Split